KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Working Capital Changes (2019 - 2025)

GoodRx Holdings' Other Working Capital Changes history spans 6 years, with the latest figure at -$14.8 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes changed N/A year-over-year to -$14.8 million; the TTM value through Dec 2025 reached $8.4 million, changed N/A, while the annual FY2025 figure was $8.4 million, N/A changed from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$14.8 million at GoodRx Holdings, down from $7.4 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $37.4 million in Q2 2021 and bottomed at -$52.9 million in Q3 2021.
  • The 4-year median for Other Working Capital Changes is $7.4 million (2025), against an average of $2.3 million.
  • The largest YoY upside for Other Working Capital Changes was 3206.54% in 2021 against a maximum downside of 289.87% in 2021.
  • A 4-year view of Other Working Capital Changes shows it stood at -$11.4 million in 2021, then soared by 192.46% to $10.5 million in 2022, then skyrocketed by 55.07% to $16.3 million in 2023, then crashed by 191.12% to -$14.8 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Other Working Capital Changes are -$14.8 million (Q4 2025), $7.4 million (Q3 2025), and $2.3 million (Q2 2025).